Table 1.
Characteristics of study population
|
Healthy sample |
Overall sample |
|||
|---|---|---|---|---|
| male | female | male | female | |
|
N |
342 |
859 |
1275 |
1577 |
|
Age , years |
46.2 ± 15.4 |
46.7 ± 13.8 |
52.5 ± 12.7 |
54.0 ± 14.9 |
|
BaPWV, cm/s |
1339.3 ± 224.8 |
1294.8 ± 241.9 |
1524.8 ± 355.7 |
1578.6 ± 463.6 |
|
BMI, kg/m2 |
23.8 ± 2.9 |
22.8 ± 2.9 |
24.7 ± 3.2 |
23.9 ± 3.4 |
|
MAP, mmHg |
89.8 ± 7.3 |
85.3 ± 8.8 |
97.9 ± 18.8 |
94.7 ± 13.3 |
|
SBP, mmHg |
123.9 ± 13.2 |
120.6 ± 12.1 |
131.8 ± 17.9 |
130.9 ± 20.9 |
|
DBP, mmHg |
74.4 ± 7.5 |
70.2 ± 8.4 |
80.9 ± 24.1 |
76.6 ± 10.9 |
|
Pulse pressure, mmHg |
46.0 ± 7.9 |
45.3 ± 9.1 |
50.9 ± 24.9 |
54.5 ± 14.9 |
|
HR, beats/min |
70.8 ± 9.4 |
71.4 ± 9.4 |
70.9 ± 10.2 |
71.6 ± 10.1 |
|
TC, mmol/L |
4.57 ± 0.81 |
4.75 ± 0.94 |
4.73 ± 0.94 |
5.09 ± 1.06 |
|
HDL-C, mmol/L |
1.37 ± 0.29 |
1.44 ± 0.33 |
1.29 ± 0.29 |
1.39 ± 0.33 |
|
LDL-C, mmol/L |
2.67 ± 0.62 |
2.75 ± 0.83 |
2.81 ± 0.76 |
3.02 ± 0.91 |
|
TG, mmol/L |
1.53 ± 1.04 |
1.31 ± 0.87 |
1.80 ± 1.27 |
1.59 ± 0.99 |
|
Fasting glucose, mmol/L |
4.9 ± 0.6 |
4.9 ± 0.5 |
5.4 ± 1.4 |
5.4 ± 1.6 |
|
Hypertension, % |
0 |
0 |
50.3 |
47.8 |
|
Diabetes, % |
0 |
0 |
23.7 |
21.1 |
|
Smoking, % |
0 |
0 |
50.2 |
3.7 |
|
Stroke, % |
0 |
0 |
7.2% |
6.5% |
|
Ischemic heart disease, % |
0 |
0 |
10.9 |
7.1 |
|
Medication |
|
|
|
|
|
ACEIs/ARBs, % |
0 |
0 |
9.9 |
8.9 |
|
Statins, % |
0 |
0 |
6.6 |
4.9 |
| CCBs, % | 0 | 0 | 15.3 | 14.5 |
BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, MAP Mean arterial pressure; BaPWV Brachial-ankle pulse wave velocity, CCBs Calcium channel blockers, ACEIs angiotensin converting enzyme inhibitors, ARBs angiotensin receptor blockers, HR heart rate, TC total cholesterol, LDL-C low density lipoprotein cholesterol, HDL-C high density lipoprotein cholesterol, TG triglyceride.